Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100.
World Infectious Disease Testing Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies is a new seven-countrystrategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimates by method (molecular, selorogy/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Worldwide Market Overview
- Estimated universe of laboratories performing
infectious disease testing by country.
- Test volume and sales projections for major
infectious disease diagnostic assays by country.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation,
reagents kits, IT and other products with significant market
appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Market Segmentation Analysis
- Sales and market shares of major suppliers
by individual test and country.
- Volume and sales forecasts for over 100 infectious disease
assays by country, individual test and market segment:
Physician Offices/Group Practices
Public Health Laboratories
- Test volume estimates by method (molecular, serology/immunodiagnostics,
- Review of the market dynamics, trends, structure, size, growth
and major suppliers by country.
Current and Emerging Products
- In-depth examination of over 100 major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.
- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,and other technologies and their potential
applications for infectious disease testing.
- Global listings of companies developing or
marketing infectious disease diagnostic products
by individual test.
- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.
Contains 1,900 pages and 850 tables
SIMILAR MARKET STUDIES
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, ...
May 2017 | $5370 | View Details >>
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimerâ€™s disease, Parkinson disease, and other neurological disorders.
May 2017 | $5370 | View Details >>
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-BarrÃ© Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022
Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.
May 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research